ADMA Biologics Inc. (ADMA)
NASDAQ: ADMA
· Real-Time Price · USD
16.95
-0.02 (-0.12%)
At close: Aug 15, 2025, 3:59 PM
17.00
0.29%
After-hours: Aug 15, 2025, 06:05 PM EDT
ADMA Biologics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 474.17M | 459.38M | 426.45M | 382.81M | 330.24M | 283.18M | 258.21M | 234.29M | 208.11M | 181.89M | 154.08M | 130.48M | 110.07M | 94M | 80.94M | 68.52M | 58.11M | 48.07M |
Cost of Revenue | 222.86M | 217.98M | 207.24M | 196.02M | 178.47M | 172.02M | 169.46M | 162.26M | 151.07M | 133.77M | 118.81M | 105.88M | 94.74M | 87.44M | 79.77M | 76.01M | 67.57M | 62.23M |
Gross Profit | 251.32M | 241.4M | 219.22M | 186.78M | 151.78M | 111.16M | 88.75M | 72.03M | 57.04M | 48.12M | 35.27M | 24.6M | 15.33M | 6.56M | 1.17M | -7.49M | -9.46M | -14.16M |
Operating Income | 155.64M | 152.04M | 138.98M | 114.89M | 83.94M | 44.27M | 21.63M | 1.34M | -16.66M | -25.36M | -39.37M | -46.5M | -51.62M | -58.02M | -58.37M | -62.4M | -61.77M | -63.31M |
Interest Income | 2.27M | 2.32M | 2.1M | 2.11M | 1.87M | 1.83M | 1.62M | 1.01M | 590.77K | 178.74K | 44.83K | 44.86K | 41.88K | 45.54K | 34.53K | 51.72K | 48.63K | 62.12K |
Pretax Income | 145.01M | 140.76M | 125.71M | 73.36M | 39.17M | -3.05M | -28.24M | -22.83M | -40.29M | -47.68M | -65.9M | -70.32M | -73.14M | -78.28M | -71.65M | -74.41M | -73.61M | -74.88M |
Net Income | 208.93M | 206.77M | 197.67M | 68.13M | 34.79M | -3.64M | -34.21M | -28.8M | -51.85M | -59.24M | -81.68M | -86.1M | -83.33M | -88.47M | -71.65M | -74.41M | -73.61M | -74.88M |
Selling & General & Admin | 89.45M | 84.78M | 77.35M | 68.97M | 65.14M | 61.84M | 59.71M | 57.38M | 55.55M | 53.27M | 52.46M | 50.26M | 48.09M | 46.56M | 42.9M | 40.5M | 38.89M | 37.15M |
Research & Development | 2.66M | 2.19M | 1.81M | 1.87M | 2.05M | 2.89M | 3.3M | 3.93M | 4.37M | 3.85M | 3.61M | 3.27M | 3M | 3.28M | 3.65M | 3.93M | 4.87M | 5.37M |
Other Expenses | 3.54M | 2.33M | 2.3M | 896.64K | -298.19K | -295.02K | 1.7M | 7.07M | 12.25M | 12.24M | 14.44M | 9.03M | 4.01M | 3.94M | -251.57K | -196.07K | -241.05K | -164.11K |
Operating Expenses | 94.34M | 88.02M | 80.21M | 71.89M | 67.84M | 66.89M | 67.12M | 70.69M | 73.7M | 73.48M | 74.63M | 71.1M | 66.95M | 64.58M | 59.55M | 54.91M | 52.31M | 49.15M |
Interest Expense | 10.19M | 12.14M | 13.93M | 17.27M | 20.16M | 22.68M | 25.03M | 24.55M | 23.73M | 22.01M | 19.28M | 16.86M | 14.58M | 13.25M | 13.06M | 12.85M | 12.64M | 12.46M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 317.22M | 306.03M | 287.47M | 267.92M | 246.3M | 238.91M | 236.58M | 232.95M | 224.77M | 207.25M | 193.44M | 176.98M | 161.69M | 152.02M | 139.32M | 130.92M | 119.88M | 111.38M |
Income Tax Expense | -63.92M | -66.01M | -71.96M | 5.22M | 4.38M | 595K | 5.98M | 5.98M | 11.56M | 11.56M | 15.78M | 15.78M | 10.19M | 10.19M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 241.49M | 237.78M | 236.43M | 234.57M | 232.42M | 228.87M | 225.97M | 225.28M | 222.68M | 221.92M | 202.83M | 196.38M | 196.35M | 195.87M | 180.81M | 133.77M | 126.04M | 115.66M |
Shares Outstanding (Diluted) | 248.61M | 244.68M | 245.9M | 244.8M | 242.17M | 236.41M | 225.97M | 233.76M | 222.68M | 221.92M | 202.83M | 196.38M | 196.35M | 195.87M | 180.81M | 133.77M | 127.42M | 115.66M |
EPS (Basic) | 0.87 | 0.87 | 0.84 | 0.29 | 0.15 | -0.02 | -0.15 | -0.13 | -0.25 | -0.29 | -0.41 | -0.44 | -0.47 | -0.55 | -0.53 | -0.64 | -0.7 | -0.78 |
EPS (Diluted) | 0.86 | 0.85 | 0.82 | 0.28 | 0.14 | -0.02 | -0.15 | -0.14 | -0.25 | -0.29 | -0.41 | -0.44 | -0.47 | -0.55 | -0.53 | -0.64 | -0.7 | -0.78 |
EBITDA | 163.11M | 160.8M | 147.34M | 98.48M | 67.35M | 27.7M | 5.12M | 9.88M | -8.63M | -18.12M | -39.51M | -46.77M | -52.3M | -59.17M | -53.1M | -56.35M | -56.14M | -58.04M |
EBIT | 155.2M | 152.9M | 139.29M | 90.27M | 59.41M | 19.7M | -2.79M | 2.15M | -16.56M | -25.68M | -46.62M | -53.46M | -58.56M | -65.03M | -58.59M | -61.56M | -60.97M | -62.42M |
Depreciation & Amortization | 7.91M | 7.9M | 8.04M | 8.21M | 8.36M | 8.41M | 8.33M | 8.16M | 7.93M | 7.56M | 7.11M | 6.69M | 6.25M | 5.86M | 5.5M | 5.21M | 4.82M | 4.38M |